Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Chondroitin Sulfate Market

Chondroitin Sulfate Market Share

Report ID: GMI3456
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Chondroitin Sulfate Market Share

Some of the major industry players operating in the Chondroitin sulfate market are

TSI Group Ltd.
Synutra Ingredients (Shandong) Co., Ltd.
Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Jiaxing Hengjie Biopharmaceutical Co., Ltd.
Qufu Liyang Biochem Industrial Co., Ltd.
Pacific Rainbow International, Inc.
Shandong Runxin Biotechnology Co., Ltd.
ZPD A/S
Guangdong Hybribio Biotech Co., Ltd
Wanbury Limited
Sierra Ingredients Pty Ltd.
BGM Pharmaceuticals Co., Ltd.
YBCC (Qingdao) Co., Ltd.
Anhui Jintung Fine Chemical Corporation Ltd.
Zhejiang Aoxing Biotechnology Co., Ltd.

These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

Market size for chondroitin sulfate was worth USD 1.24 billion in 2022 and is poised to reach USD 1.74 billion by 2032 owing to its growing popularity as a natural supplement to support joint functions and reduce discomfort.

Chondroitin sulfate market from the bovine sources segment generated USD 0.36 billion in revenue in 2022 and is anticipated to witness steady growth by 2032 owing to the widespread availability of bovine cartilage due to the large cattle industry.

U.S. market for chondroitin sulfate was worth USD 0.32 billion in 2022 and is set to expand at a notable CAGR from 2023-2032 driven by the growing health awareness and the strong desire to maintain active lifestyles among consumers in the country.

Some top firms in the chondroitin sulfate are TSI Group Ltd., Synutra Ingredients (Shandong) Co., Ltd., Yantai Dongcheng Pharmaceutical Group Co., Ltd., Jiaxing Hengjie Biopharmaceutical Co., Ltd., Qufu Liyang Biochem Industrial Co., Ltd., and Pacific Rainbow International, Inc.